A Phase II Study of Rivoceranib for Patients With Recurrent or Metastatic Olfactory Neuroblastoma
Clinical trial NCT06308575 · WITHDRAWN
Trial details
- NCT number
- NCT06308575
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-01
- Primary completion
- 2024-11-05
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.